Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Isolation Market

Cell Isolation Market Analysis

  • Report ID: GMI6469
  • Published Date: Aug 2023
  • Report Format: PDF

Cell Isolation Market Analysis

Based on the product, the cell isolation market is segmented into consumables and instruments. Consumables are further segmented into reagents, kits, media & sera, beads, and disposables. The instruments segment is divided into centrifuges, cell sorters, magnetic-activated cell separator systems, and filtration systems. Beads are further bifurcated into magnetic beads and fluorescent beads. In 2022, consumables held the largest market share of 62.2%. Consumables refer to the products and materials that are used up or depleted during the process of isolating cells from a biological sample. They play a critical role in the success of cell isolation procedures, and their quality can significantly impact the reliability and reproducibility of experimental results. Researchers and technicians working in the cell isolation field need to ensure that they use high-quality consumables that are compatible with their specific isolation protocols and cell.
 

Based on the cell type, the cell isolation market is classified into human cells and animal cells. Human cells are further subdivided into differentiated cells and stem cells. Due to increasing incidence of chronic and infectious diseases such as cancer, the human cells segment held the largest market share in 2022 and is expected to grow at CAGR of 12.2% during the forecast period. Differentiated cells are mature and specialized cells that have undergone a process of cellular differentiation, wherein they have developed specific structures and functions to perform specialized tasks in the body. Whereas stem cells are undifferentiated cells with the unique ability to self-renew and differentiate into various specialized cell types. These cells are isolated and utilized for various research, therapeutic, and diagnostic purposes.
 

Based on the cell source, the global cell isolation market is divided into bone marrow, adipose tissues, cord blood/ embryonic stem cells, and other cell sources. Bone marrow segment dominated the global cell isolation market and was valued at USD 2.5 billion in 2022. Bone marrow is a soft, spongy tissue found inside certain bones of the body. It is a vital part of the human hematopoietic system and plays a crucial role in the production of blood cells and immune cells. Due to rising cancer cases, bone marrow has been utilised in hematological malignancies, such as leukemia, lymphoma, and multiple myeloma. Bone marrow is involved in both the diagnosis and treatment of these cancers. As the cases of cancer, its diagnosis and treatment are increasing the bone marrow segment will rise further.
 

Cell Isolation Market Share, By Technique (2022)

Based on the technique, the cell isolation market is fragmented into centrifugation-based cell isolation, surface-based cell isolation, and filtration-based cell isolation. In 2022, centrifugation-based cell isolation segment accounted for significant market share of 43.8% and is expected to grow at CAGR of 11.4% during the forecast timeframe. Centrifugation-based cell isolation is a commonly used method for separating different cell types from a heterogeneous cell population based on their density differences. This technique relies on the principle that cells with different densities will settle at different rates when subjected to centrifugal force. Due to its availability, affordability and global utilisation in institutes and research labs, this segment held the largest market share in 2022. The increasing demand for innovative techniques in research & development will drive the growth of this segment.
 

Based on the application, the cell isolation market is classified into biomolecule isolation, cancer research, stem cell therapy research, tissue regeneration/ regenerative medicines, in-vitro diagnostics, and other applications.  The biomolecule isolation segment is expected to grow at CAGR of 13.1% and is expected to reach USD 5.5 billion by 2032. Biomolecule isolation is a crucial process in cell isolation. It involves the separation and purification of specific biomolecules such as proteins, nucleic acids, lipids, and carbohydrates from complex biological samples. Isolating biomolecules allows to study their structure, function, and interactions, leading to a better understanding of biological processes and the development of new therapies and technologies. Moreover, rising need for high efficacious drugs in cancer and chronic diseases resistant to treatment, biomolecule isolation is rapidly increasing leading to the growth of the market.
 

Based on the end-user, the cell isolation market is divided into pharmaceutical & biotechnology companies, research & academic institutes, hospitals & diagnostic laboratories, and other end-users. In 2022, the pharmaceutical & biotechnology segment accounted for highest market share of 51.3%. Due to advancement in drug discovery and development, cell-based therapies, precision medicine, diagnostic assays and cell sorting techniques, the pharmaceutical & biotechnology companies are growing at a rapid pace. As modern technology continues to evolve, it will lead to even more significant breakthroughs in pharmaceutical and biotechnological segments.
 

U.S. Cell Isolation Market Size, 2020- 2032 (USD Billion)

In 2022, the North American cell isolation market held the largest share of 42.8%. It is due to a considerable increase patient pool of chronic diseases, government funding for cancer research and advancement of pharmaceutical & biotechnological sector. Additionally, the increasing prevalence of diseases, introduction of novel approaches in cell isolation, increasing research centers and labs, rising number of innovation equipment will increase the growth in this region.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market for cell isolation size was valued to be USD 5.2 billion in 2022 and is expected to reach over USD 16 billion by 2032, driven by the rising prevalence of chronic and infectious diseases such as cancer and COVID-19, government support for cell-based research, and growing emphasis on customized therapy.

Due to increasing incidence of chronic and infectious diseases such as cancer, the human cells segment held the largest market share in 2022 and is expected to grow at CAGR of 12.2% during 2023 to 2032.

North American cell isolation market accounted for revenue share of 42.8% in 2022 and will continue to grow through 2032, due to a considerable increase in patient pool of chronic diseases, and government funding for cancer R&D in pharmaceutical & biotechnological sector.

Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Corning Inc., STEMCELL Technologies Inc., Invent Biotechnologies, Qiagen NV, Alfa Laval AB, Sartorius AG, and Bio-Techne Corporation.

Cell Isolation Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 632
  • Countries covered: 20
  • Pages: 370
 Download Free Sample